The clinical significance of plasmatic amyloid Aß40 peptide levels in Alzheimer’s disease patients treated with galantamine.

24/11/2008

Del Modrego P., Monleón I., Sarasa M. al 24/11/2008

Referencia: American Journal of Alzheimer’s Disease and Other Dementia 23, 286-290